« Previous
Next »
Fertility and Sterility
Volume 91, Issue 5
, Pages
1848-1852
, May 2009
Dehydroepiandrosterone sulfate and insulin resistance in patients with polycystic ovary syndrome
To access this article, please choose from the options below
R. A. is a consultant for Merck & Co., Pfizer, Procter & Gamble, and Quest Diagnostics. K.B. has nothing to disclose. A.H. has nothing to disclose.
Supported in part by National Institutes of Health grants R01-HD2364 and K24-HD01346-01, and the Helping Hand of Los Angeles, Inc., Los Angeles, California.
Presented in part at the 62nd Annual Meeting of the American Society for Reproductive Medicine, New Orleans, LA, October 21–25, 2006.
PII: S0015-0282(08)00366-X
doi: 10.1016/j.fertnstert.2008.02.101
© 2009 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
Fertility and Sterility
Volume 91, Issue 5
, Pages
1848-1852
, May 2009

